Julie Beitz

3.5k total citations · 1 hit paper
39 papers, 2.0k citations indexed

About

Julie Beitz is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Julie Beitz has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Julie Beitz's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Julie Beitz is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Julie Beitz collaborates with scholars based in United States, Thailand and Japan. Julie Beitz's co-authors include A. Raymond Frackelton, Peter Bross, Richard Pazdur, Atiqur Rahman, Sandip Kumar Roy, Eamon Duffy, Grant Williams, R N Sridhara, Xi Chen and Gang Chen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Julie Beitz

39 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.

2001 660 citations Peter Bross, Julie Beitz et al. PubMed profile →

Peers

Julie Beitz

ONCOL

IMMUN

HEMAT

RNMI

Gregory D. Ayers United States

Susan L. Kelley United States

Arthur G. Pratt United Kingdom

Bingbing Yang China

Yukitaka Ueki Japan

Leo B. A. Van De Putte Netherlands

Chan Zeng United States

Samuel A. Jacobs United States

María José Santos Portugal

Patricia A. Fraser United States

Gregory D. Ayers United States

Julie Beitz

961 ×1.4

792 ×1.6

ONCOL

273 ×0.8

IMMUN

227 ×0.7

HEMAT

303 ×1.0

RNMI

Citations per year, relative to Julie Beitz Julie Beitz (= 1×) peers Gregory D. Ayers

Countries citing papers authored by Julie Beitz

Since Specialization

Citations

This map shows the geographic impact of Julie Beitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Beitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Beitz more than expected).

Fields of papers citing papers by Julie Beitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Beitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Beitz. The network helps show where Julie Beitz may publish in the future.

Co-authorship network of co-authors of Julie Beitz

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Beitz. A scholar is included among the top collaborators of Julie Beitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Beitz. Julie Beitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Miao, et al.. (2023). Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model. British Journal of Clinical Pharmacology. 91(4). 1003–1015. 1 indexed citations

Joffe, Hylton V., Christina Y. Chang, Catherine Sewell, et al.. (2015). FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder. New England Journal of Medicine. 374(2). 101–104. 72 indexed citations

Brinker, Allen, Lawrence Goldkind, Renan A. Bonnel, & Julie Beitz. (2004). Spontaneous Reports of Hypertension Leading to Hospitalisation in Association with Rofecoxib, Celecoxib, Nabumetone and Oxaprozin. Drugs & Aging. 21(7). 479–484. 19 indexed citations

Shaffer, Douglas, Karen M. Higgins, Peter K. Honig, et al.. (2003). Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign. Pharmacoepidemiology and Drug Safety. 12(3). 177–182. 18 indexed citations

Bonnel, Renan A., Lois La Grenade, Claudia B. Karwoski, & Julie Beitz. (2003). Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. Journal of the American Academy of Dermatology. 48(2). 294–296. 20 indexed citations

Ahmad, Syed Rizwanuddin, Cindy Kortepeter, Allen Brinker, Min Chen, & Julie Beitz. (2002). Renal Failure Associated with the Use of Celecoxib and Rofecoxib. Drug Safety. 25(7). 537–544. 85 indexed citations

Brinker, Allen & Julie Beitz. (2002). Spontaneous reports of thrombocytopenia in association with quinine: Clinical attributes and timing related to regulatory action. American Journal of Hematology. 70(4). 313–317. 26 indexed citations

Bonnel, Renan A., María L. Villalba, Claudia B. Karwoski, & Julie Beitz. (2002). Aseptic Meningitis Associated With Rofecoxib. Archives of Internal Medicine. 162(6). 713–713. 30 indexed citations

Bross, Peter, Julie Beitz, Gang Chen, et al.. (2001). Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.. PubMed. 7(6). 1490–6. 660 indexed citations breakdown →

10.

Beitz, Julie. (2001). Trial endpoints for drug approval in oncology: Chemoprevention. Urology. 57(4). 213–215. 4 indexed citations

11.

Wysowski, Diane K., et al.. (2001). An analysis of reports of depression and suicide in patients treated with isotretinoin. Journal of the American Academy of Dermatology. 45(4). 515–519. 159 indexed citations

12.

Hershberg, Robert M., Paul E. Framson, Susan Kovats, et al.. (1997). Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.. Journal of Clinical Investigation. 100(1). 204–215. 174 indexed citations

13.

Clark, Jeffrey R., Frank J. Cummings, Marcia Browne, et al.. (1996). Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 122(9). 554–558. 6 indexed citations

14.

Davol, Pamela A., Julie Beitz, & A. Raymond Frackelton. (1995). Autocrine Down-Regulation of Basic Fibroblast Growth Factor Receptors Causes Mitotoxin Resistance in a Human Melanoma Cell Line. Journal of Investigative Dermatology. 104(6). 916–921. 9 indexed citations

15.

Davol, Pamela A., et al.. (1995). Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model. Cancer. 76(1). 79–85. 10 indexed citations

16.

Beitz, Julie, Frank J. Cummings, Marcia Browne, et al.. (1995). Phase I Trial of High-Dose Infused Zidovudine Combined with Leucovorin plus Fluorouracil. Cancer Investigation. 13(5). 464–469. 4 indexed citations

17.

Weitberg, Alan B., John Yashar, Arvin S. Glicksman, et al.. (1993). Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. European Journal of Cancer. 29(4). 511–515. 21 indexed citations

18.

Beitz, Julie, et al.. (1992). Receptors for platelet-derived growth factor on microvascular endothelial cells. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 61. 85–90. 9 indexed citations

19.

Posner, Marshall R., Peter A. Calabresi, I. Brunetti, et al.. (1990). Oral Zidovudine, Continuous-Infusion Fluorouracil, and Oral Leucovorin Calcium: A Phase I Study. JNCI Journal of the National Cancer Institute. 82(21). 1710–1714. 20 indexed citations

20.

Posner, Marshall R., et al.. (1989). A Phase I/II Trial of 5-Fluorouracil and Etoposide in Metastatic Colorectal Carcinoma. American Journal of Clinical Oncology. 12(6). 491–493. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact